A carregar...
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation in Myeloma.
BACKGROUND: High-dose chemotherapy with autologous stem cell transplantation has been the standard treatment for young patients with newly diagnosed myeloma. However, promising emerging data with the combination of lenalidomide, bortezomib and dexamethasone (RVD) have raised questions about the role...
Na minha lista:
| Publicado no: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6201242/ https://ncbi.nlm.nih.gov/pubmed/28379796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1611750 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|